MRUS Similar Chart Price Prediction
The price of MRUS is predicted to go up -14.45%, based on the high correlation periods with CATO. The similarity of these two price pattern on the periods is 93.2%.
MRUS
CATO
Down: -14.45%Similarity: 93.2%
MRUS Revenue Forecast
MRUS EPS Forecast
MRUS FAQs
What is bull’s view on MRUS?
What is bear's view on MRUS?
What is MRUS revenue forecast for next quarter？
What is MRUS eps forecast for next quarter？
MRUS Analyst's Forecast
Michael Schmidt
Guggenheim
Strong Buy
2024-12-03
Price Target
$111 → $109
Upside
+135.88%
Guggenheim lowered the firm's price target on Merus to $109 from $111 and keeps a Buy rating on the shares after the company announced an exclusive agreement with privately-held Partner Therapeutics to exclusively licensed to PTx the right to commercialize zenocutuzumab for the treatment of NRG1 fusion-positive cancer in the U.S. The firm is updating its model to account for the license agreement, the analyst tells investors.
David Dai
UBS
Strong Buy
2024-10-24
Price Target
$72
Upside
+37.67%
Michael Schmitz
Guggenheim
Strong Buy
2024-10-01
Price Target
$93 → $111
Upside
+121.56%
